← Back

$ Value

$0

Shares

621,727

Price

$0

Filed

Apr 7

Insider

Name

Agah Ramtin

Title

Chief Medical Officer

CIK

0001862617

Roles

Director Officer

Transaction Details

Transaction Date

2026-04-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

621,727

Footnotes

On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 621,727 shares of the Issuer's common stock (319,073 shares of which are underlying incentive stock options and 302,654 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036.

Filing Info

Accession No.

0001493152-26-015591

Form Type

4

Issuer CIK

0001574094

Agah Ramtin's History

Date Ticker Type Value
2026-04-03 RNXT A $0
2026-01-21 RNXT $10K
2025-12-31 RNXT $8K
2025-12-30 RNXT $169
2025-12-16 RNXT $10K
2025-12-05 RNXT $10K
2025-11-24 RNXT $10K
2025-11-21 RNXT $8K
2025-07-01 RNXT A $0
2025-06-05 RNXT $29K

Other Insiders at RNXT (90d)

Insider Bought Sold Last
VOLL MARK
Chief Financial Officer
2026-04-03
Marton Laurence 2026-03-20
Bagai Shaun
Chief Executive Officer
2026-04-03
Gentry Leesa
Chief Clinical Officer
2026-04-03